Published in J Nutr on April 29, 2009
Metabolic fate of polyphenols in the human superorganism. Proc Natl Acad Sci U S A (2010) 1.34
Role of the normal gut microbiota. World J Gastroenterol (2015) 1.12
Bioavailability of dietary polyphenols and gut microbiota metabolism: antimicrobial properties. Biomed Res Int (2015) 1.00
Apigenin and naringenin suppress colon carcinogenesis through the aberrant crypt stage in azoxymethane-treated rats. Exp Biol Med (Maywood) (2010) 0.94
Flavone deglycosylation increases their anti-inflammatory activity and absorption. Mol Nutr Food Res (2012) 0.83
Role of pomegranate and citrus fruit juices in colon cancer prevention. World J Gastroenterol (2014) 0.82
The Chemistry of Gut Microbial Metabolism of Polyphenols. Phytochem Rev (2016) 0.78
Phytochemicals for the Management of Melanoma. Mini Rev Med Chem (2016) 0.77
Disposition of flavonoids via recycling: Direct biliary excretion of enterically or extrahepatically derived flavonoid glucuronides. Mol Nutr Food Res (2016) 0.75
Flavones: Food Sources, Bioavailability, Metabolism, and Bioactivity. Adv Nutr (2017) 0.75
Pharmacological Basis for Use of Selaginella moellendorffii in Gouty Arthritis: Antihyperuricemic, Anti-Inflammatory, and Xanthine Oxidase Inhibition. Evid Based Complement Alternat Med (2017) 0.75
Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol (2006) 3.82
Decline in presumptively protective gut bacterial species and metabolites are paradoxically associated with disease improvement in pediatric Crohn's disease during enteral nutrition. Inflamm Bowel Dis (2014) 2.59
Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation (2006) 2.41
Absence of intestinal microbiota does not protect mice from diet-induced obesity. Br J Nutr (2010) 2.17
Development of the intestinal bacterial composition in hospitalized preterm infants in comparison with breast-fed, full-term infants. Pediatr Res (2003) 2.07
Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4. PLoS One (2007) 2.05
Oligonucleotide probes that detect quantitatively significant groups of butyrate-producing bacteria in human feces. Appl Environ Microbiol (2003) 1.77
Antibiotics in dust originating from a pig-fattening farm: a new source of health hazard for farmers? Environ Health Perspect (2003) 1.43
Commensal Akkermansia muciniphila exacerbates gut inflammation in Salmonella Typhimurium-infected gnotobiotic mice. PLoS One (2013) 1.30
Fructans in the diet cause alterations of intestinal mucosal architecture, released mucins and mucosa-associated bifidobacteria in gnotobiotic rats. Br J Nutr (2003) 1.26
Reclassification of Eubacterium formicigenerans Holdeman and Moore 1974 as Dorea formicigenerans gen. nov., comb. nov., and description of Dorea longicatena sp. nov., isolated from human faeces. Int J Syst Evol Microbiol (2002) 1.22
Determination of persistent tetracycline residues in soil fertilized with liquid manure by high-performance liquid chromatography with electrospray ionization tandem mass spectrometry. Anal Chem (2002) 1.17
Anaerostipes caccae gen. nov., sp. nov., a new saccharolytic, acetate-utilising, butyrate-producing bacterium from human faeces. Syst Appl Microbiol (2002) 1.17
Quercetin inhibits TNF-induced NF-kappaB transcription factor recruitment to proinflammatory gene promoters in murine intestinal epithelial cells. J Nutr (2007) 1.16
Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants. Pediatr Res (2008) 1.14
Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study. J Clin Microbiol (2006) 1.13
Innate mechanisms for Bifidobacterium lactis to activate transient pro-inflammatory host responses in intestinal epithelial cells after the colonization of germ-free rats. Immunology (2005) 1.11
Isolation of bacteria from the ileal mucosa of TNFdeltaARE mice and description of Enterorhabdus mucosicola gen. nov., sp. nov. Int J Syst Evol Microbiol (2009) 1.11
Clostridium saccharogumia sp. nov. and Lactonifactor longoviformis gen. nov., sp. nov., two novel human faecal bacteria involved in the conversion of the dietary phytoestrogen secoisolariciresinol diglucoside. Syst Appl Microbiol (2007) 1.10
Effects of supplemented isoenergetic diets differing in cereal fiber and protein content on insulin sensitivity in overweight humans. Am J Clin Nutr (2011) 1.09
Role of commensal gut bacteria in inflammatory bowel diseases. Gut Microbes (2012) 1.08
Intestinal bacterial communities that produce active estrogen-like compounds enterodiol and enterolactone in humans. Appl Environ Microbiol (2005) 1.06
Modulation of gut mucosal biofilms. Br J Nutr (2005) 1.03
Long-term stability of the human gut microbiota in two different rat strains. Curr Issues Mol Biol (2008) 1.02
The Toll-like receptors TLR2 and TLR4 do not affect the intestinal microbiota composition in mice. Environ Microbiol (2007) 1.01
Intestinimonas butyriciproducens gen. nov., sp. nov., a butyrate-producing bacterium from the mouse intestine. Int J Syst Evol Microbiol (2013) 1.00
Human intestinal microbiota: characterization of a simplified and stable gnotobiotic rat model. Gut Microbes (2011) 1.00
Occurrence and activity of human intestinal bacteria involved in the conversion of dietary lignans. Anaerobe (2005) 0.99
Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation. PLoS One (2009) 0.99
Reduced microbial diversity and high numbers of one single Escherichia coli strain in the intestine of colitic mice. Environ Microbiol (2009) 0.97
Metabolic assessment of gradual development of moderate experimental colitis in IL-10 deficient mice. J Proteome Res (2009) 0.97
Quantification of human fecal bifidobacterium species by use of quantitative real-time PCR analysis targeting the groEL gene. Appl Environ Microbiol (2012) 0.96
Anaerobic C-ring cleavage of genistein and daidzein by Eubacterium ramulus. FEMS Microbiol Lett (2002) 0.96
Lignan transformation by gut bacteria lowers tumor burden in a gnotobiotic rat model of breast cancer. Carcinogenesis (2011) 0.94
Anaerobic degradation of flavonoids by Clostridium orbiscindens. Appl Environ Microbiol (2003) 0.94
Isoflavones and functional foods alter the dominant intestinal microbiota in postmenopausal women. J Nutr (2005) 0.94
Isolation of a human intestinal bacterium capable of daidzein and genistein conversion. Appl Environ Microbiol (2009) 0.93
Conversion of daidzein and genistein by an anaerobic bacterium newly isolated from the mouse intestine. Appl Environ Microbiol (2008) 0.92
Requirement of purine and pyrimidine synthesis for colonization of the mouse intestine by Escherichia coli. Appl Environ Microbiol (2010) 0.92
Phylogeny of human intestinal bacteria that activate the dietary lignan secoisolariciresinol diglucoside. FEMS Microbiol Ecol (2006) 0.90
Adaptation of protein expression by Escherichia coli in the gastrointestinal tract of gnotobiotic mice. Environ Microbiol (2008) 0.90
Impact of gut microbiota on intestinal and hepatic levels of phase 2 xenobiotic-metabolizing enzymes in the rat. Drug Metab Dispos (2009) 0.89
The gastrointestinal microbiota affects the selenium status and selenoprotein expression in mice. J Nutr Biochem (2008) 0.89
Recent developments and perspectives in the investigation of probiotic effects. Int J Med Microbiol (2009) 0.89
Identification and expression of genes involved in the conversion of daidzein and genistein by the equol-forming bacterium Slackia isoflavoniconvertens. Appl Environ Microbiol (2013) 0.88
Cloning and expression of a phloretin hydrolase gene from Eubacterium ramulus and characterization of the recombinant enzyme. Appl Environ Microbiol (2004) 0.88
Daidzein and genistein are converted to equol and 5-hydroxy-equol by human intestinal Slackia isoflavoniconvertens in gnotobiotic rats. J Nutr (2011) 0.88
Bioavailability of lignans in human subjects. Nutr Res Rev (2006) 0.86
Differences in mucosal gene expression in the colon of two inbred mouse strains after colonization with commensal gut bacteria. PLoS One (2013) 0.86
Transformation of flavonoids by intestinal microorganisms. Int J Vitam Nutr Res (2003) 0.86
Mutagenicity of arbutin in mammalian cells after activation by human intestinal bacteria. Food Chem Toxicol (2006) 0.86
Intestinal steroid profiles and microbiota composition in colitic mice. Gut Microbes (2011) 0.85
The thermal and enzymatic taxifolin-alphitonin rearrangement. J Nat Prod (2011) 0.85
Changes in dominant groups of the gut microbiota do not explain cereal-fiber induced improvement of whole-body insulin sensitivity. Nutr Metab (Lond) (2011) 0.84
Deglycosylation of puerarin and other aromatic C-glucosides by a newly isolated human intestinal bacterium. Environ Microbiol (2010) 0.83
The peptide transporter PEPT1 is expressed in distal colon in rodents and humans and contributes to water absorption. Am J Physiol Gastrointest Liver Physiol (2013) 0.83
Recovery and metabolism of xanthohumol in germ-free and human microbiota-associated rats. Mol Nutr Food Res (2010) 0.82
Bacterial transformation of dietary lignans in gnotobiotic rats. FEMS Microbiol Ecol (2010) 0.81
Occurrence of the human tumor-specific antigen structure Galβ1-3GalNAcα- (Thomsen-Friedenreich) and related structures on gut bacteria: prevalence, immunochemical analysis and structural confirmation. Glycobiology (2011) 0.80
Purification and characterization of an NADH oxidase from Eubacterium ramulus. Arch Microbiol (2002) 0.80
Posttranslational inhibition of proinflammatory chemokine secretion in intestinal epithelial cells: implications for specific IBD indications. J Clin Gastroenterol (2010) 0.80
Xanthohumol does not affect the composition of rat intestinal microbiota. Mol Nutr Food Res (2005) 0.80
Marker rescue studies of the transfer of recombinant DNA to Streptococcus gordonii in vitro, in foods and gnotobiotic rats. Appl Environ Microbiol (2003) 0.80
Conversion of dehydrodiferulic acids by human intestinal microbiota. J Agric Food Chem (2009) 0.80
Clostridium asparagiforme sp. nov., isolated from a human faecal sample. Syst Appl Microbiol (2005) 0.79
The growth of the flavonoid-degrading intestinal bacterium, Eubacterium ramulus, is stimulated by dietary flavonoids in vivo. FEMS Microbiol Ecol (2002) 0.79